Sma-and Mad-related protein 4 (SMAD4) is the central mediator of the transforming growth factor beta signaling pathway and is closely related to mammalian reproductive ability and the development of ovarian follicles. However, little is currently known about the role of SMAD4 in mammalian follicular granulosa cell (GC) apoptosis or its regulation by miRNAs. Here, we found that the porcine SMAD4 protein was expressed at high levels in GCs and oocytes from primary, preantral, and antral follicles, and only slightly expressed in theca cells; its expression level was down-regulated in apoptotic ovarian GCs, suggesting that SMAD4 may be involved in ovary development and selection. Overexpression and knockdown of SMAD4 increased the proliferation and apoptosis of cultured porcine GCs, respectively. In addition, the use of miRNA mimics and luciferase reporter assays revealed that miRNA-26b (miR26b) functions as a proapoptotic factor in porcine follicular GCs by targeting the 3 0 -untranslated region of the SMAD4 gene.
INTRODUCTION
The transforming growth factor b (TGF-b)-signaling pathway plays a critical role in controlling follicle formation, ovulation, and atresia in mammalian ovaries. As the central component of the canonical TGF-b-signaling pathway, Smaand Mad-related protein 4 (SMAD4) was the first tumor suppressor gene reported [1] and is the only common mediator SMAD (co-SMAD) identified to date. Recent studies demonstrated that SMAD4 is expressed widely in mammalian tissues [2] ; moreover, it is involved in a number of crucial biological processes, including cell proliferation, apoptosis, and differentiation [3, 4] , signal transduction [5] , embryonic development [6] , and tissue and organ growth and development [7, 8] as well as diseases and tumorigenesis [9] [10] [11] . In mammalian ovaries, SMAD4 is localized mainly in oocytes and granulosa cells (GCs) but is scarcely located in stromal cells [12] , suggesting that it is an important regulatory factor in mammalian follicular development.
In a previous study [13] , the serum progesterone concentration was reduced significantly in ovary-or GC-specific Smad4-knockout mice, possibly due to abnormal steroidogenesis; in addition, preantral follicular atresia was increased significantly, the number of antral follicles was reduced significantly, and follicular growth retardation was observed in these mice. Along with the observed high levels of luteinizing hormone, all of these outcomes caused premature ovarian failure in the Smad4-knockout mice, leading to lower fertility, infertility, or smaller litter sizes. By contrast, a different study found there were no significant effects of oocyte-specific Smad4-knockout on the histological features of mouse ovarian follicles at different developmental stages, or the reproductive performance (including litter size) of the animals [14] . Taken together, these observations suggest that SMAD4 has functional roles in ovarian tissues, particularly GCs.
In mammals, SMAD4 expression is regulated by transcription factors such as Sp1 [15] and COUP transcription factor II [16] , interacting proteins such as protein kinase A [5] , and epigenetic modifications such as DNA methylation [17] , histone acetylation [18] , histone methylation [19, 20] , SUMOylation [21] , and ubiquitylation and deubiquitylation [22] . MicroRNAs (miRNAs) also control SMAD4 expression [23] , and this method of regulation is the most widely studied at present [24, 25] . These small (approximately 20-23 nucleotide) double-stranded noncoding RNAs are highly conserved across different mammalian species and have universal functions in a series of diseases and physiological processes [26] . In 2007, Murchison et al. [27] used a specific knockout of Dicer, the key miRNA-processing enzyme, to show that miRNAs play an important role in the ovary. Subsequently, a number of other researchers began to focus on the roles of miRNAs in the ovary [28] . Carletti et al. [29] showed that miR-21 regulates mouse ovulation and ovarian GC apoptosis in vivo, and Yao et al. [30] reported that miR-224 promotes GC proliferation in mice by targeting the Smad4 gene. However, the role of SMAD4 in domestic animal follicular GC proliferation and apoptosis and its regulation by miRNAs are currently unknown. Here, we report that the expression of pig SMAD4 is regulated by miR-26b, which is highly conserved in mammals, and shows significant differential expression during the porcine follicular atresia. We also investigate whether this regulation influences the expression of apoptosis-related genes as well as follicular GC proliferation, apoptosis, and atresia in the porcine ovary.
MATERIALS AND METHODS

Animals
The ovaries of mature Erhualian sows were obtained from the Changzhou Erhualian Pig Production Cooperation (Jiangsu, China) for section preparation. Pig ovaries were collected from mature sows at a local slaughterhouse for GCs isolation and culture. During the procedure, electrodes were used to ensure that the pigs were in an unconscious state. All the animal experiments were approved by the Animal Ethics Committee at Nanjing Agricultural University, China.
Immunohistochemistry
The isolated ovaries were fixed overnight with 4% paraformaldehyde and then embedded in paraffin. Endogenous peroxidase activity was blocked by treatment of the tissues with 3% hydrogen peroxide. After incubating with 5% bovine serum albumin in phosphate-buffered saline to block nonspecific binding, the ovaries were incubated with a rabbit polyclonal anti-SMAD4 primary antibodies (diluted 1:150, Santa Cruz) and then biotin-labeled secondary antibodies. The nuclei were counterstained with hematoxylin (Sigma). Staining with normal immunoglobulin G (Santa Cruz) was performed as negative control (NC). The immunohistochemistry studies were based on three experimental repeats and five follicles per condition. A total of three pigs were used.
Cell Culture
GCs were collected from porcine ovarian follicles (3-5 mm diameter). The cells were seeded into T25 flasks and cultured at 378C and 5% CO 2 in DMEM/ F-12 medium (Gibco) containing 15% fetal bovine serum (FBS) (Gibco), 100 units/ml penicillin, and 100 mg/ml streptomycin (Gibco). HeLa 229 cells were incubated at 378C and 5% CO 2 in DMEM containing 10% FBS.
RNA Interference
The cells were transfected with a SMAD4-specific or NC nonsense small interfering RNA (siRNA) using Lipofectamine RNAiMAX reagent (Invitrogen), according to the manufacturer's instructions. The sequences of the SMAD4-and NC-siRNAs are listed in Supplemental Table S1 (Supplemental Data are available online at www.biolreprod.org).
Overexpression of SMAD4
The SMAD4 cDNA was amplified using primer P1 (Supplemental Table  S2 ) and the cDNA collected from the porcine ovary as a template. The forward primer introduced a HindIII site, and the reverse primer introduced a XhoI site; after digestion with these restriction enzymes, the PCR product was inserted into the pcDNA3.1 (þ) vector (Invitrogen) and the recombinant plasmid was verified by sequencing. For transfection, the cells were seeded into a 6-well plate at a density of 5 3 10 5 cells/well, incubated overnight at 378C, and then transfected with the recombinant pcDNA3.1-SMAD4 plasmid or empty vector as a control using Lipofectamine 2000 reagent (Invitrogen). The culture medium containing plasmid was replaced with fresh medium 6 h after transfection.
Quantitative RT-PCR
Total RNA was isolated from all the samples using TRIzol reagent (Invitrogen) and then reverse transcribed to cDNA using MMLV reverse transcriptase and oligo (dT)18 (Promega). The 20-ll quantitative RT-PCR (qRT-PCR) reactions were performed with SYBR Premix Ex Taq (TaKaRa) by using the following parameters: 958C for 30 sec followed by 40 cycles of 958C for 5 sec, annealing for 5 sec and 728C for 30 sec. The expression level of GAPDH was used as the internal control and fold changes were calculated using the 2 À44CT method. Assays were performed in triplicate, and data are expressed as the mean 6 SEM. The primer sequences are listed in Supplemental Table S2 .
Western Blot Analysis
GCs were collected 48 h after transfection, and whole cell lysates were prepared in RIPA buffer (50 mM Tris HCl, pH 8, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 1% Triton X-100, and proteinase inhibitors) (Sigma). The total protein concentration was quantified using the Bradford method, and 15 lg of each sample were separated in a 4%-12% SDS-PAGE gel (Invitrogen) and then transferred onto a nitrocellulose membrane. The membrane was blocked by incubating for 2 h at room temperature with 2% bovine serum albumin in 20 mM Tris-HCl, 150 mM NaCl, and 0.05% Tween 20. The membrane was then incubated at 48C overnight with a diluted (1:1500) monoclonal anti-SMAD4 antibody or anti-GAPDH antibody as an internal control, followed by a secondary antibody (1:2000) for 2 h at room temperature. The specific complexes were visualized using SuperSignal West Pico chemiluminescent substrate. Densitometric analysis was performed to quantify the signal intensity.
Methyl Thiazolyl Tetrazolium Assay
For methyl thiazolyl tetrazolium (MTT) assays, GCs were seeded into 96-well plates and transfected with pcDNA3.1-SMAD4 or empty pcDNA3.1 vector as a control. Cell proliferation was assessed at 24 and 48 h posttransfection using the Cell Proliferation Assay Kit (Promega), according to the manufacturer's protocol. Statistical comparisons were by Student t-tests performed using GraphPad StatMate software (GraphPad Software).
Annexin V-Fluorescein Isothiocyanate/Propidium Iodide Double-Staining Assay
Cell apoptosis was analyzed using the Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) apoptosis detection kit (KeyGEN), according to the manufacturer ' s instructions. Briefly, adhered cells in 6-well plates were digested with 0.25% ethylenediaminetetraacetic acid-free trypsogen, and then cell membranes with exposed phosphatidylserines were visualized by annexin V-FITC staining under dark conditions. The cells were counterstained with FITC-labeled annexin V and PI at 48C for 5 min. Finally, the numbers of stained cells were determined using a FACS (fluorescenceactivated cell sorter) Calibur flow cytometer (BD Biosciences).
Plasmid Construction and Dual-Luciferase Assay
SMAD4 was predicted in silico as a target of miR-26b. To verify whether SMAD4 is a target of miR-26b in vitro, a fragment of the porcine SMAD4 3 0 -untranslated region (3 0 -UTR) harboring the putative miR-26b binding site was amplified from ovary total RNA using primer P6 (Supplemental Table S2 ) and then inserted into the pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega) at the XbaI and SacI restriction sites. The miR-26b target site in the SMAD4 3 0 -UTR was mutated from TACTTGA to GCAAACT using the P7 and P8 primer (Supplemental Table S2 ) and the TaKaRa MutanBEST Mutagenesis Kit (Takara). The amplified products were confirmed by DNA sequencing. HeLa 229 cells were transfected with the constructed plasmids and miR-26b or NC mimics. The firefly and Renilla luciferase activities in the cell lysates were determined using a dual-luciferase assay system (Promega), and normalized data were calculated as the ratio of the Renilla/firefly luciferase activities.
TGF-b1 Stimulation
Porcine GCs were treated with recombinant human TGF-b1 (0, 5, 10, and 20 ng/ml) (R&D Systems) under serum-starved conditions (0.5% FBS). The miRNAs were isolated using TRIzol reagent (Invitrogen) and then reverse transcribed using PrimeScript miRNA qPCR Starter Kit Ver.2.0 (TakaRa). Quantitative RT-PCR was performed using the SYBR PrimeScript miRNA RT-PCR Kit (Takara) with the following cycling parameters: 958C for 2 min followed by 40 cycles of 958C for 15 sec and 608C for 30 sec. The sequence of the forward primer corresponding to the miR-26b sequence was 5 0 -CCG GTT TGG ATA TTT TTG TAC TTG AT-3 0 . The expression level of U6 small nuclear RNA was used as an internal control.
Statistical Analysis
Statistical analyses were performed using SPSS v17.0 For Windows (SPSS Inc.). A two-tailed Student t-test and ANOVA were used to evaluate the statistical significance of the differences in the results of our experiments. P , 0.05 and P , 0.01 were considered as significant and highly significant, respectively. LIU ET AL.
RESULTS
SMAD4 Is Expressed Widely in the Pig Ovary
To understand its biological function in follicular development in the pig, the expression pattern and localization of the SMAD4 protein in porcine ovaries were examined by immunohistochemistry. As shown in Figure 1 , SMAD4 was expressed widely in different developmental stages of the ovary follicles. The primary follicles were surrounded by several layers of flattened follicular cells; at this stage, SMAD4 was expressed mainly in oocytes (Fig. 1B) . During development, the primary follicles transformed into early preantral follicles that had several layers of GCs surrounding the oocyte; at this stage, SMAD4 was expressed in the cytoplasm and nuclei of the oocytes and GCs (Fig. 1C) . In the more developed preantral follicles, the oocytes exhibited strong positive staining for SMAD4 protein; however, its expression level was very low in the theca cells (Fig. 1D) . When the preantral follicles became antral follicles, the oocytes were surrounded by a group of GCs and squeezed to the side of the follicles, thereby forming cumulus-oocyte complexes that had an antrum filled with follicular fluids; at this stage, the oocytes and GCs exhibited very strong positive staining for SMAD4, but the theca cells maintained low levels of expression of the protein (Figs. 1D) . After ovulation, the luteal cells also showed strong staining for the SMAD4 protein (Fig. 1E) . It is well known that approximately 70%-99% of GCs undergoing atresia manifested loose GCs and shrinkage, and then dislodge into the cavity shown in Figure 1 , B and F (black arrows). Here, we found that the expression of SMAD4 was decreased visibly in the GCs and oocytes of atretic follicles. These results suggest that SMAD4 may be an important regulator of follicular development in pig ovary.
Inhibition of SMAD4 Induces Apoptosis in Pig GCs
GCs play a major role in deciding the fate of follicles; in particular, follicular atresia is triggered by GC apoptosis [31] . To explore its role in follicular atresia and GC apoptosis, RNA interference was used to knockdown SMAD4 expression in pig follicular GCs cultured in vitro. A qRT-PCR analysis confirmed that, compared with GCs transfected with the NCsiRNA, those transfected with the SMAD4-siRNA had significantly lower SMAD4 mRNA levels (P , 0.01, 7.94-fold change) ( Fig. 2A) . In agreement with the mRNA level, the level of SMAD4 protein was also down-regulated significantly as a result of the specific siRNA treatment (P , 0.01, 1.69-fold change) (Fig. 2B) . A flow cytometry analysis revealed that the apoptosis rate of the SMAD4-siRNA group was significantly higher than that of the NC-siRNA group (P , 0.01) (Fig. 2C) . In addition, compared with that in the NC-siRNA group, the expression level of the antiapoptotic BCL-2 gene was decreased significantly in the SMAD4-siRNA group (P , 0.05, 1.71-fold change), while that of the proapoptotic BAX gene was not changed (P . 0.05) (Fig. 2D) . The results indicate that inhibition of SMAD4 expression enhances GC apoptosis in the follicles of porcine ovaries.
Overexpression of SMAD4 Promotes GC Proliferation
To examine the functions of SMAD4 in pig GCs further, the full-length coding region of the SMAD4 gene was cloned into the eukaryotic expression vector pcDNA3.1, which was then transfected into porcine GCs cultured in vitro. As expected, the expression level of the SMAD4 protein was significantly higher in GCs transfected with the pcDNA3.1-SMAD4 (Fig. 3A) . A MTT assay revealed that GC proliferation was increased significantly after transfection with the pcDNA3.1-SMAD4 expression vector (P , 0.05) (Fig. 3B) , suggesting that overexpression of SMAD4 promotes GC proliferation in porcine follicles.
Identification of miRNAs that Target SMAD4
The experiments described above showed that SMAD4 plays a critical role in porcine follicular GC proliferation and apoptosis and has distinct expression patterns at different stages of follicular development. To investigate the mechanism of regulation of SMAD4 in pig GCs, the effects of miRNAs on SMAD4 expression were examined. First, miRNAs that may regulate SMAD4 expression were identified by combining the computational predictions of three popular prediction algorithms, namely miRBD [32] , miRWalk [33] , and TargetScan [34] . This approach identified 323 putative miRNAs that may regulate the SMAD4 gene (Supplemental Table S3 ). According to the results of our previous microarray study [35] , 17 of these 323 miRNAs were differentially expressed during follicular atresia processes (Fig. 4A) . Among the 14 miRNAs that were up-regulated during follicular atresia, miR-26b was the third most significantly elevated miRNA. Furthermore, miR-26b was also the most conserved among the top three differentially expressed miRNAs (miR-936, miR-320c, and miR-26b) in mammals. We retrieved the mature sequences of the miR-26b genes from 14 vertebrates from the miRBase database and found that these genes share a common seed region (ucaaguaa) and are highly conserved (Fig. 4B) . To verify whether miR-26b is able to bind to the pig SMAD4 gene, the 3 0 -UTR of this gene was isolated ( Supplemental Fig. S1 ). Alignment of the miR26b seed sequence with the 3 0 -UTR of SMAD4 from pig and other vertebrates showed complementary pairing (Fig. 4C) . In addition, previous data demonstrated that miR-26b played an important role in cell proliferation and apoptosis [35, 36] ; therefore, miR-26b was selected for further analysis.
The Porcine SMAD4 Gene Is Regulated by miR-26b
To determine whether miR-26b is able to regulate SMAD4 gene expression, the putative miR-26b target sites in the porcine SMAD4 3 0 -UTR were cloned downstream of the luciferase gene in the pmirGLO dual-luciferase reporter vector to generate pmirGLO-SMAD4-3 0 -UTR (Fig. 5A) . HeLa 229 cells were transiently cotransfected with the reporter plasmid and miR-26b or NC mimics. Overexpression of exogenous miR-26b repressed the activity of the luciferase reporter fused to the SMAD4 3 0 -UTR (P , 0.01) (Fig. 5B) ; however, the luciferase activity was not altered significantly when the cells were cotransfected with the miR-26b mimics and a SMAD4 reporter 3 0 -UTR construct containing a mutation in the miR26b binding site (P . 0.05) (Fig. 5C ). These results suggest that miR-26b can regulate the expression of the porcine SMAD4 gene by binding to conserved sites in its 3 0 -UTR.
MicroRNA-26b Promotes Pig GC Apoptosis by Targeting the SMAD4 Gene
To determine whether miR-26b plays a role in controlling apoptosis of porcine follicular GCs, miR-26b or NC mimics were transfected into cultured GCs and the level of apoptosis was detected using antiannexin V FITC/PI staining and flow cytometry analysis. Cell apoptosis was significantly higher in GCs transfected with miR-26b mimics than those transfected with NC mimics (P , 0.05) (Fig. 6A) . In addition, miR-26b PROMOTER GC APOPTOSIS BY TARGETING SMAD4 overexpression of miR-26b reduced the expression level of the antiapoptotic BCL-2 gene significantly (P , 0.05, 4.07-fold change), but had no effect on the expression level of the proapoptotic BAX gene (P . 0.05) (Fig. 6B) . These results indicate that miR-26b is a proapoptotic factor in porcine follicular GCs.
To confirm that miR-26b promotes GC apoptosis by targeting the SMAD4 gene, the SMAD4 mRNA and protein levels were measured after transfection of cultured GCs with miR-26b or NC mimics. Quantitative RT-PCR analysis revealed that the SMAD4 mRNA expression level was significantly lower in the miR-26b mimics-transfected GCs than the NC mimics-transfected GCs (P , 0.01, 1.21-fold change) (Fig. 6C) . Furthermore, the SMAD4 protein expression level was also down-regulated significantly in the cells overexpressing endogenous miR-26b (P , 0.01, 4.78-fold Negative control porcine ovary. B-E) The expression of SMAD4 in the primary follicles (B; white arrows), GCs and oocytes in early preantral follicles (C), antral follicles (D), and corpus luteum cells (E). The black arrows indicate atretic follicles (F). Pr, primary follicles; PA, preantral follicles; AF, antral follicles; A, atretic follicles. G, granulosa cell; T, theca cell; CL, corpus luteum cell. Original magnification 3100, bar ¼ 100 lm (A, B, E); 3200, bar ¼ 50 lm (C, D) ; 320, bar ¼ 500 lm (F).
LIU ET AL. change) (Fig. 6D) . These results suggest that miR-26b regulates pig GC apoptosis by targeting the SMAD4 gene.
TGF-b1 Down-Regulates miR-26b Expression in Porcine GCs
SMAD4 is the last signaling molecule in the TGF-bsignaling pathway, and its expression is regulated by upstream signaling molecules such as the TGF-b ligand itself [23, 30] . To determine the effect of the TGF-b-signaling pathway on miR26b expression, porcine GCs were treated with varying concentrations of recombinant human TGF-b1 (0, 5, 10, or 20 ng/ml) and then the isolated RNAs were examined by qRT-PCR. Compared to untreated control cells, the level of miR-26b was significantly reduced in a dose-dependent manner by 6.41-, 14-, and 17.89-fold upon stimulation with 5, 10, and 20 ng/ml TGF-b1 respectively (P , 0.01) (Fig. 7A) . Contrary to the miR-26b expression, SMAD4 mRNA expression was significantly up-regulated by TGF-b1 in GCs (P , 0.01, 1.86-fold change) (Fig. 7B) . In addition, GC apoptosis was dramatically inhibited by TGF-b1 (P , 0.05) (Fig. 7C) . These data indicate that miR-26b is regulated by upstream signaling molecules of the TGF-b pathway.
DISCUSSION
SMAD-signaling pathways, including the TGF-b/SMAD and bone morphogenetic protein (BMP)/SMAD pathways, are key regulators of growth and differentiation, which are essential for female reproduction. Dysregulation of Smadsignaling pathways can cause reproductive disorders such as female infertility and polycystic ovary syndrome [12, 37, 38] . In the mammalian ovary, signaling molecules involved in SMAD-signaling pathways are expressed in a cell-type and stage-dependent manner; for example BMP15, GDF9, and BMPR-1B are expressed in oocytes, whereas TGF-b1, BMP2, BMP6, and Smads are expressed in follicular somatic cells (granulosa, thecal, and luteal cells) [37, 39, 40] . SMAD4 is the only comediated SMAD protein and is the core signaling molecule in SMAD-signaling pathways; however, reports of its distribution in the mammalian ovary and expression during follicular development are limited [12] , and, to our knowledge, there are no previous reports of the distribution and expression of SMAD4 in pigs. The results presented here demonstrate that, in the porcine ovary, the SMAD4 protein is expressed mainly in GCs and oocytes rather than theca cells. In the human ovary, SMAD4 expression increased during follicle maturation and decreased during follicular atresia [12] . In contrast, a previous study of the mouse ovary demonstrated similar expression levels of SMAD4 in oocytes of preantral and antral follicles [41] . The altered expression levels at different follicular stages observed here suggest that SMAD4 may play a role in regulating porcine follicular development.
The ligands of the SMAD-signaling pathways regulate cell function through the formation of membrane-bound heteromeric complexes consisting of serine-threonine kinase receptors (called type II and type I receptors) and intracellular Smad proteins. These complexes bind to the common mediator SMAD4 and then translocate to the nucleus to activate target genes; hence, SMAD4 is the central component of the signaling pathway in the mammalian ovary [13, 14, 42] . Homozygous Smad4 knockout mice die before Day 7.5 of embryogenesis [43, 44] . Ovarian-specific or immature developing follicular GC-specific Smad4 knockout mice display multiple defects in folliculogenesis, premature luteinization of GCs, premature ovarian failure, and subfertility with decreasing fertility over time [13] . By contrast, selective knockout of Smad4 in the preovulatory follicles of mice results in ovulation defects and subfertility, but does not cause premature luteinization [42] . However, minimal fertility defects do occur in mice deficient in oocyte-expressed Smad4 [14] , suggesting that SMAD4 has a major function in GCs in the mammalian ovary. As mentioned above, reports of the roles of SMAD4 in livestock ovaries are currently limited [3] . The results presented here help to define the physiological role of SMAD4 in the porcine ovary by showing that knockdown and overexpression of SMAD4 promotes pig ovarian GC apoptosis and proliferation, respectively; these results are consistent with the effects of GC-specific depletion of Smad4 in mice [14, 42] . Wang et al. [3] also reported that RNA interference-mediated knockdown of SMAD4 inhibits follicle stimulating hormone-induced proliferation of pig GCs. Furthermore, Chang et al. [45] reported that knockdown of SMAD4 suppresses the effects of BMP15 on Cx43 expression in human GCs and gap junction intercellular communication activity. These data suggest that SMAD4 affects the ovarian function and reproductive performance of pigs by regulating the state (proliferation or apoptosis) of GCs and the fate (growth or atresia) of follicular development [31] .
Because of its important role in the SMAD-signaling pathway, understanding the regulation of SMAD4 expression is important [15, 21, 22, 46] . Regulation of SMAD4 expression 
miR-26b PROMOTER GC APOPTOSIS BY TARGETING SMAD4
by miRNAs plays a role in the control of multiple physiological and pathological processes, including stem cell specification (miR-125 [47] ) and directional differentiation (miR-4448 [48] ), hepatic stellate cell proliferation (miR-146a [49] ), chondrocyte apoptosis (miR-146a [50] ), skeletal muscle differentiation and regeneration (miR-26a [24] ), follicular GC growth (miR-224 [30] ), cancer cell proliferation (miR-888 [51] ), migration (miR-20a [52] ), and invasion (miR-1260b [46] ), and disease development (miR-26a [53] , miRNA-199a-5p [54] ). However, little is currently known about the regulation of SMAD4 expression by miRNAs in the mammalian ovary. MiR-224 regulates TGF-b-mediated mouse GC proliferation and function by targeting SMAD4 [30] . Furthermore, the expression level of miR-224 in equine follicles is inversely correlated with that of SMAD4 [55] , and p53/p65 can up-regulate SMAD4 expression by inhibiting miR-224 in mouse ovarian GCs [56] . Despite these findings, our previous study revealed no significant changes in miR-224 expression during porcine follicular atresia [35] . The results presented here demonstrate that miR-26b binds directly to the 3 0 -UTR of SMAD4 in porcine follicular GCs. MiR-26b is encoded by the intron of the RNA polymerase II C-terminal domain small phosphatase 1 gene and plays a number of roles in various mammalian cells [57] . For example, Zhu et al. [57] found that miR-26b expression is increased in quiescent cells and decreased during cell proliferation, and that it inhibits the G1/S transition by activating the pRb protein. In vitro, miR26b increases the number of DNA breaks and promotes porcine GC apoptosis by targeting the ataxia telangiectasia mutated gene [35] . In addition, miR-26b inhibits adipocyte proliferation and promotes adipocyte differentiation by targeting the sheddase ADAM17 [58] and the phosphatase and tensin homolog gene [59] . In breast cancer, miR-26b inhibits tumor growth and the estrogen-stimulated growth of estrogen receptor-positive cells by targeting the CHD1, GREB1, and KPNA2 genes [36] and enhances cell migration and invasion by targeting the TNKS1BP1, CPSF7, and COL12A1 genes [60] . Antagonism of miR-26b attenuates hepatocellular carcinoma cell apoptosis by inhibiting the expression of TGF-bactivated kinase-1 and its adaptor TAB3 [61] . The data presented here also provide evidence that miR-26b can regulate follicular GC apoptosis and follicular atresia in domestic animals by directly targeting the SMAD4 gene.
A recent study indicated that the deubiquitinating enzyme USP9X (ubiquitin-specific peptidase 9, X-linked) was a target of miR-26b in hepatocellular carcinoma cells, and miR-26b inhibited epithelial-mesenchymal transition in hepatocellular carcinoma cells through the SMAD4-and the TGF-b-signaling pathway by targeting USP9X [62] . Dupont et al. [63] demonstrated that USP9X controls monoubiquitination of SMAD4 and is essential for the TGF-b-signaling pathway. Hence, we postulated that miR-26b would indirectly regulate the expression of SMAD4 by targeting USP9X in porcine GCs. Indeed, we found that miR-26b was able to bind to the 3 0 -UTR of porcine USP9X gene by using the bioinformatic/in silico predictive methods (Fig. 8A) . By qRT-PCR, we also found that FIG. 7 . The effects of TGF-b1 on miR-26b, SMAD4 expression, and cell apoptosis in porcine GCs. A) TGF-b1 down-regulates miR-26b expression in GCs. RT-PCR analyses of miR-26b expression in porcine GCs treated with recombinant human TGF-b1 (0, 5, 10, and 20 ng/ml). The miR-26b expression levels were normalized to those of U6. Different uppercase letters represent the difference of expression levels are significant (P , 0.01). B) TGF-b1 induces SMAD4 expression in GCs. C) TGF-b1 inhibits GC apoptosis. Data are represented as the mean 6 SEM from three independent experiments. *P , 0.05.
the mRNA level of USP9X significantly decreased in GCs after transfection of miR-26b mimics (P , 0.01, 2.69-fold change) (Fig. 8B) . In light of the findings of Dupont et al. [63] , it is conceivable that miR-26b may inhibit the activity of the deubiquitinating enzyme USP9X by binding to its 3 0 -UTR in GCs and that both the ubiquitination of SMAD4 and its entrance into the nucleus may be impeded, thereby leading to the functional suppression of SMAD4. These results indicated that miR-26b not only directly targets and regulates SMAD4 but may also indirectly control SMAD4 expression by targeting USP9X in GCs. In addition, these two miR-26b targets, SMAD4 and USP9X, are involved in human ovarian function and fertility [64, 65] . As such, miR-26b perhaps functions as a stimulator for female fertility and serves as a potential nonhormonal drug for controlling reproduction and contraception.
SMAD4 expression is regulated by upstream signaling molecules in the TGF-b-signaling pathway, including the TGFb ligand itself [23, 30] . MiR-224 is significantly up-regulated in mouse GCs treated with TGF-b1 and promotes mouse ovarian GC proliferation and estrogen release by targeting SMAD4 [30] . MiR-199a also represses SMAD4 expression and blocks canonical TGF-b transcriptional responses in human cancer cell lines [23] . Similarly, miR-130a [66] , miR-146A [49] , miR-454 [67] , and other miRNAs are also involved in TGF-b signaling. In addition, it was also found that TGF-b1 significantly up-regulated the expression of two miR-26b targets in GCs, SMAD4 (Fig. 7B) and USP9X (Fig. 8C) . The results presented here show that, like other miRNAs targeting SMAD4, miR-26b is also regulated by upstream signaling molecules and forms a regulatory network together with the TGF-b pathway.
In summary, the findings described here provide novel mechanistic insights into the role of SMAD4 in follicular GC proliferation and apoptosis in the porcine ovary. MiR-26b can promote GC apoptosis by directly targeting the SMAD4 gene and indirectly regulating deubiquitination of SMAD4 protein by targeting USP9X in the pig ovary (Fig. 8D ). These findings suggest that both miR-26b and SMAD4 play important roles in follicular atresia, ovary development and female reproduction.
